Jon Rowley,
Chief Executive And Technology Officer,
Rooster Bio Inc
Jon A. Rowley, PhD, is the Chief Executive and Technical Officer of RoosterBio Inc and has a personal goal of making significant contributions to the commercial translation of living cellular technologies. Jon holds a PhD from the University of Michigan in Biomedical Engineering and has authored over 30 peer reviewed manuscripts and 20 issued or pending patents related to biomaterials development, tissue engineering, and cellular therapy. He most recently spent 5 years as Director of Innovation and Process Development in Lonza’s Cell Therapy CMO business, and currently resides in Walkersville, MD with his wonderful wife and their 3 young children.
Why Manufacturing Matters: How Today’s Cell Therapy BioProcess Innovations are Laying the Foundation for a Sustainable Tissue Engineering Revolution
Tuesday, 10 February 2015 at 13:30
Add to Calendar ▼2015-02-10 13:30:002015-02-10 14:30:00Europe/LondonWhy Manufacturing Matters: How Today’s Cell Therapy BioProcess Innovations are Laying the Foundation for a Sustainable Tissue Engineering RevolutionSELECTBIOenquiries@selectbiosciences.com
Technology is rapidly moving toward the integration of biologics into
products like cell therapies, engineered tissues, bio-robotics,
implantable devices, 3D printing, food, clothing, and even toys. This
coming decade will see the incorporation of living cells into all these
platforms and others not yet imagined. To expedite this biologics
revolution, inventors, developers and suppliers will require a
limitless, standardized, low-cost supply of living cells – and today’s
cell therapy bio-manufacturing innovations are laying the groundwork to
make this a reality.
Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonClinical Applications and Clinical Translation of Tissue EngineeringSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2015-02-10 13:30:002015-02-10 14:30:00Europe/LondonWhy Manufacturing Matters: How Today’s Cell Therapy BioProcess Innovations are Laying the Foundation for a Sustainable Tissue Engineering RevolutionSELECTBIOenquiries@selectbiosciences.com
